Youngjun Oh

Title: Youngjun Oh: Innovator in Vaccine Development

Introduction

Youngjun Oh is a prominent inventor based in Owensboro, KY (US). He has made significant contributions to the field of vaccine development, particularly in the area of virus and antigen conjugation. With a total of 2 patents, his work is paving the way for innovative solutions in combating infectious diseases.

Latest Patents

Youngjun Oh's latest patents focus on vaccines formed by virus and antigen conjugation. The first patent discloses methods of forming compounds and exemplary compounds in the nature of a conjugated compound. This includes an antigen and virus particle mixed in a conjugation reaction to create a conjugate mixture. The conditions and steps involved in forming these products allow for their use as vaccines against various pathogens, including those responsible for diseases caused by novel coronaviruses, such as SARS-COV 2. The second patent similarly outlines methods for creating stable conjugated compounds at refrigerated or room temperature, emphasizing their potential as effective vaccines.

Career Highlights

Youngjun Oh is currently associated with Kbio Holdings Limited, where he continues to advance his research and development efforts. His innovative approach to vaccine formulation has garnered attention in the scientific community, contributing to the ongoing fight against infectious diseases.

Collaborations

Some of Youngjun Oh's notable coworkers include Steven D Hume and Leigh Burden. Their collaborative efforts enhance the research environment and foster innovation within their projects.

Conclusion

Youngjun Oh's work in vaccine development exemplifies the critical role of inventors in addressing global health challenges. His patents on virus and antigen conjugation represent a significant advancement in the field, showcasing his commitment to improving public health through innovative solutions.